Free sialic acid storage disorder: Progress and promise

Marjan Huizing , Mary E Hackbarth , David R Adams , Melissa Wasserstein
Neuroscience letters 755 135896 -135896

20
2021
Amino acid metabolism

Raymond Y Wang , William R Wilcox , Stephen D Cederbaum
Emery Rimoin’s Essent. Med. Genet. 372 1 -42

13
2013
RGX-111 gene therapy for the treatment of severe mucopolysaccharidosis type I (MPS I): Interim analysis of data from the first in human study

Raymond Y Wang , Can H Ficicioglu , Roberto Giugliani , Jenna Burke
Molecular Genetics and Metabolism 138 ( 2) 107354 -107354

1
2023
2024
Vestronidase alfa for the treatment of mucopolysaccharidosis type VII (MPS VII): Updated results from a novel, longitudinal, multi-center disease monitoring program (DMP)

Roberto Giugliani , Christina L Grant , Maurizio Scarpa , Angela Sun
Molecular Genetics and Metabolism 141 ( 2) 107851 -107851

2024
Vestronidase alfa for the treatment of mucopolysaccharidosis type VII (MPS VII): Updated results from a novel, longitudinal, multicenter Disease Monitoring Program (DMP)

Roberto Giugliani , Antonio Gonzalez-Meneses Lopez , Christina Grant , Maurizio Scarpa
Molecular Genetics and Metabolism 138 ( 2) 107117 -107117

2023
Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohort

Barry J Byrne , Steven D Colan , Priya S Kishnani , Meredith C Foster
Cardiology in the Young 32 ( 3) 364 -373

8
2022
Collaborative research efforts drive therapeutic advancements for free sialic acid storage disorder (FSASD)

May Christine Malicdan , David R Adams , PJ Brooks , Konstantin Dobrenis
Molecular Genetics and Metabolism 141 ( 2) 107948 -107948

2024
disease type C; clinical experience in four cases [version 1; peer

William RH Evans , Elena-Raluca Nicoli , Raymond Y Wang , Nina Movsesyan

2017
disease type C; clinical experience in four cases

William RH Evans , Elena-Raluca Nicoli , Raymond Y Wang , Nina Movsesyan

2017
Problemas médicos únicos en pacientes adultos con mucopolisacaridosis

John Mitchell , Kenneth I Berger , Andrea Borgo , Elizabeth A Braunlin
Revista europea de medicina interna

The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII.

Raymond Y Wang , José Francisco da Silva Franco , Jaime López-Valdez , Esmeralda Martins
Molecular Genetics and Metabolism 129 ( 3) 219 -227

4
2020
Long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis type VII

Raymond Y Wang , JOSE FRANCO , Jaime López-Valdez , Esmeralda Martins
Molecular Genetics and Metabolism

2020
Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227].

Raymond Y Wang , José Francisco da Silva Franco , Jaime López-Valdez , Esmeralda Martins
Molecular Genetics and Metabolism 131 285

2020
Elevated oxysterol and N‐palmitoyl‐O‐phosphocholineserine levels in congenital disorders of glycosylation

An N Dang Do , Irene J Chang , Xutian Jiang , Lynne A Wolfe
Journal of inherited metabolic disease 46 ( 2) 326 -334

3
2023
A concerted action to explore therapies for free sialic acid storage disease

Marjan Huizing , Steven U Walkley , Melissa Wasserstein , Christine Anne-Longin
Molecular Genetics and Metabolism 138 ( 2) 107160 -107160

2023
A long-term observation of ophthalmology assessment in atypical CLN2 patients receiving ICV cerliponase alfa treatment

Audrey Kao , Harriet Chang , Rahul Bhola , Raymond Y Wang
Molecular Genetics and Metabolism 141 ( 2) 107910 -107910

2024
Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.

Sara E Mole , Angela Schulz , Eben Badoe , Samuel F Berkovic
Orphanet Journal of Rare Diseases 16 ( 1) 185 -185

2021
Exploring Pompe disease: Insights into the natural history of novel Gaac. 1826dupA knock-in murine model

Jerry F Harb , Shih-hsin Kan , Nancy D Dalton , Alejandra Padilla
Molecular Genetics and Metabolism 141 ( 2) 107873 -107873

2024